Scheme showing the potential oncogenic cascades involved in the malignant and aggressive phenotypes of melanoma stem/progenitor cells. The intracellular signalling cascades induced through the activation of distinct growth factor pathways which may provide a critical role for the sustained growth, survival, migration, invasion, metastases and/or drug resistance of melanoma stem/progenitor cells, are shown. These tumorigenic cascades include sonic hedgehog SHH/PTCH (patched receptor)/GLI, Cripto-Nodal-ALK4/7/ActRIIB activin-like kinases receptor complex, CD133 pentaspan transmembrane protein, Notch/Ligand (Delta and Jagged), hyaluronan (HA)/CD44 and Wnt/Frizzled (Fzd)/β-catenin. The up-regulated expression levels of certain target gene products including up-regulated cyclin D1, c-Myc, Bcl-2, Nodal, N-cadherin, matrix metalloproteinase (MMPs), urokinase plasminogen (uPA), cyclooxygenase (COX-2) and vascular epidermal growth factor (VEGF) that can contribute to the malignant transformation of melanoma stem/progenitor cells are also indicated. In addition, the potential molecular targeting strategies by using a selective inhibitor of SMO hedgehog signalling element (cyclopamine), Nodal (Lefty), EGFR (gefitinib or erlotinib), γ-secretase and monoclonal antibody (mAb) directed against Cripto-1, CD133 and ABC multidrug transporter.